SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?


To: Michael Bidder who wrote (988)12/15/1997 1:53:00 PM
From: Bill Wexler  Read Replies (3) | Respond to of 7041
 
<<If a company is buying back stock can the insiders still sell.>>

Yes, and very often they do.

One of the biggest red flags to a short-seller is when a marginal company suddenly announces a token share buyback immediately after a drop in the stock price.

One of the things that really startled me about ZONA was the low short interest. I guess this one has been flying under the radar of the general short-selling community until Asensio started writing his reports. I was watching the price/volume activity over the past few days and it is fairly obvious the stock is being dumped...and fast. There is absolutely no support from short covering. I believe that Asensio's target of <5 a share is quite likely.



To: Michael Bidder who wrote (988)12/15/1997 6:11:00 PM
From: Claud B  Respond to of 7041
 
Long or short, when you put your money on the line, it always
helps to know the correct name of the company.

It's Zonagen....not Zonagine.

Claud